Venture firms back NZ-based biotech company(2)

New Zealand-based biotechnology company CoDa Therapeutics has raised $20 million of venture capital funding. It is the latest example of increased venture appetite for biotech companies in the region.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this